ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Henry Brem Named Director Of Neurology At Johns Hopkins.

July 28, 2000

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014

In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval

August 1, 1975

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

NIEHS Uses Gene Chips To Evaluate Chemicals.

March 3, 2000

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008